Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

MA Konstam, JD Neaton, K Dickstein, H Drexler… - The Lancet, 2009 - thelancet.com
Summary Background Angiotensin-receptor blockers (ARBs) are effective treatments for
patients with heart failure, but the relation between dose and clinical outcomes has not been …
被引用次数：805 相关文章

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

MA Konstam, JD Neaton, K Dickstein, H Drexler… - The Lancet, 2009 - thelancet.com
Summary Background Angiotensin-receptor blockers (ARBs) are effective treatments for
patients with heart failure, but the relation between dose and clinical outcomes has not been …

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

MA Konstam, JD Neaton, K Dickstein, H Drexler… - The Lancet, 2009 - hero.epa.gov
Background Angiotensin-receptor blockers (ARBs) are effective treatments for patients with
heart failure, but the relation between dose and clinical outcomes has not been explored …
[PDF] academia.edu

[PDF][PDF] Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

MA Konstam, JD Neaton, K Dickstein, H Drexler… - 2009 - academia.edu
Summary Background Angiotensin-receptor blockers (ARBs) are effective treatments for
patients with heart failure, but the relation between dose and clinical outcomes has not been …
[PDF] psu.edu

[PDF][PDF] Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

MA Konstam, JD Neaton, K Dickstein, H Drexler… - Lancet, 2009 - Citeseer
Summary Background Angiotensin-receptor blockers (ARBs) are effective treatments for
patients with heart failure, but the relation between dose and clinical outcomes has not been …

[引用][C] Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

MA Konstam, JD Neaton, K Dickstein… - The …, 2009 - produccioncientifica.ucm.es

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

MA Konstam, JD Neaton, K Dickstein, H Drexler… - THE LANCET, 2009 - iris.uniroma1.it
BACKGROUND: Angiotensin-receptor blockers (ARBs) are effective treatments for patients
with heart failure, but the relation between dose and clinical outcomes has not been …

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial.

MA Konstam, JD Neaton, K Dickstein… - Lancet (London …, 2009 - europepmc.org
Background Angiotensin-receptor blockers (ARBs) are effective treatments for patients with
heart failure, but the relation between dose and clinical outcomes has not been explored …

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

MA Konstam, JD Neaton, K Dickstein, H Drexler… - The Lancet, 2009 - Elsevier
BACKGROUND: Angiotensin-receptor blockers (ARBs) are effective treatments for patients
with heart failure, but the relation between dose and clinical outcomes has not been …

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

MA Konstam, JD Neaton, K Dickstein, H Drexler… - The …, 2009 - experts.umn.edu
Background: Angiotensin-receptor blockers (ARBs) are effective treatments for patients with
heart failure, but the relation between dose and clinical outcomes has not been explored …